Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonist Us

    2026-04-14

    (S)-(+)-Dimethindene maleate: Practical Guidance for Selective M2 Antagonism

    What This Product Solves

    (S)-(+)-Dimethindene maleate is a small molecule with high selectivity for the muscarinic acetylcholine receptor subtype M2 and concurrent antagonism of histamine H1 receptors. Its dual action allows researchers to dissect receptor-specific signaling in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. The compound's selectivity for M2 over M1, M3, and M4 receptors minimizes off-target effects, providing a reliable pharmacological tool for receptor selectivity profiling (product_spec).

    For a detailed look at how this compound supports scalable extracellular vesicle workflows and advanced cardiopulmonary models, see the article (S)-(+)-Dimethindene Maleate: Precision Pharmacology for ..., which explores applications distinct from standard receptor studies. Additionally, (S)-(+)-Dimethindene Maleate: Unlocking Receptor Selectiv... discusses its role in advancing regenerative medicine workflows.

    Protocol Parameters

    • compound dissolution | ≥20.45 mg/mL (water) | stock solution preparation for in vitro assays | Ensures maximum solubility and reproducibility in standard aqueous buffers | product_spec
    • storage conditions | room temperature, desiccated | all routine storage prior to experimental use | Preserves compound integrity and specified purity (98.00%) | product_spec
    • solution stability | use immediately after preparation; avoid long-term storage | short-term experiments (<12 hours) | Minimizes degradation and activity loss in solution | product_spec
    • working concentration | workflow-dependent; typically start with low micromolar range | receptor binding and functional assays | Begin with conservative concentrations, titrate based on assay sensitivity and receptor expression | workflow_recommendation

    Workflow Setup and QC Checklist

    • Compound Handling: Weigh (S)-(+)-Dimethindene maleate using a calibrated microbalance. Confirm mass against required molarity for your working solution.
    • Solution Preparation: Dissolve in molecular-grade water to a concentration not exceeding 20.45 mg/mL. Filter-sterilize if using in cell-based assays to prevent contamination.
    • Aliquoting: Prepare only the amount needed for immediate use; do not store diluted solutions longer than necessary.
    • Documentation: Record lot number, preparation date, and storage conditions in your lab notebook or LIMS for traceability.
    • QC Testing: Verify solution clarity and pH after dissolution. If using in functional assays, run a vehicle control to ensure baseline signal.
    • Receptor Profiling: Use validated positive and negative control antagonists to benchmark assay selectivity for muscarinic acetylcholine receptor signaling pathway analysis.

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If the compound does not fully dissolve at the maximum recommended concentration, confirm water purity and gently vortex. If persistent, reduce concentration and reattempt.
    • Compound Degradation During Storage: Storing dissolved solutions for extended periods can lead to loss of activity. Always prepare fresh solutions as per product guidance.
    • Non-Specific Effects in Assays: High concentrations may induce off-target antagonism or cytotoxicity. Perform initial titrations and include appropriate controls to identify and mitigate such risks.
    • Batch Variability: Always confirm the purity (98.00%) and batch number with each new order or lot. Document any deviations from expected biological activity.

    Scope and Limitations

    • Intended Use: (S)-(+)-Dimethindene maleate is for in vitro research applications only. It should not be used for diagnostic, therapeutic, or clinical purposes.
    • Receptor Selectivity: While highly selective for M2 muscarinic and H1 histamine receptors, confirmation of selectivity under specific assay conditions is advised to rule out context-dependent off-target effects.
    • Storage and Handling: Activity and purity are contingent on proper storage (dry, room temperature). Deviation from recommended conditions may compromise results (product_spec).
    • Evidence Boundaries: Protocol guidance is based on product specification and established workflow practices; direct paper-based efficacy data for this specific SKU are presently unavailable.

    Conclusion

    (S)-(+)-Dimethindene maleate is a practical and selective M2 muscarinic receptor antagonist, supporting high-fidelity studies in autonomic regulation, cardiovascular physiology, and respiratory system function. Adhering to best practices in handling, solubility, and assay setup will maximize experimental reproducibility. For full technical details and ordering, refer to the APExBIO product page. Use is strictly limited to scientific research; clinical or diagnostic applications are not supported by current specifications.